Edition:
India

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

32.19CAD
22 Jun 2018
Change (% chg)

$-0.67 (-2.04%)
Prev Close
$32.86
Open
$32.27
Day's High
$32.56
Day's Low
$31.78
Volume
1,161,127
Avg. Vol
1,231,863
52-wk High
$36.02
52-wk Low
$14.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1,995.00 -7.679
FY 2017 Dec '17 2,163.00 -1.309
Sep '17 2,219.00 3.693
Jun '17 2,233.00 -0.109
Mar '17 2,109.00 1.792
FY 2016 Dec '16 2,402.60 -1.472
Sep '16 2,479.60 -3.486
Jun '16 2,420.20 -0.876
Mar '16 2,371.60 -1.084
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 14 2,058.25 2,113.00 1,975.60 2,090.90
Quarter Ending Sep-18 14 2,100.33 2,209.80 2,038.90 2,079.60
Year Ending Dec-18 17 8,300.88 8,470.50 8,157.50 8,846.07
Year Ending Dec-19 16 8,447.24 8,810.00 8,053.80 9,030.76
Earnings (per share)
Quarter Ending Jun-18 14 0.78 0.90 0.69 0.94
Quarter Ending Sep-18 14 0.83 0.98 0.70 1.08
Year Ending Dec-18 15 3.33 3.60 3.00 3.81
Year Ending Dec-19 14 3.53 3.94 3.25 4.41
LT Growth Rate (%) 3 2.19 5.80 -2.00 -9.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. 55.49 40.70 45.73
P/E Low - Last 5 Yrs. 55.49 23.63 24.23
Beta -0.36 0.89 0.88
Price to Sales (TTM) 0.54 3.94 5.71
Price to Book (MRQ) 1.28 4.81 5.37
Price to Tangible Book (MRQ) -- 5.61 6.94
Price to Cash Flow (TTM) 3.62 22.91 23.32
% Owned Institutions 66.84 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.73 2.24 7.89
Sales (TTM) vs TTM 1 Yr. Ago -10.57 4.83 5.68
Sales - 5 Yr. Growth Rate 31.85 10.08 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.61 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago -14.59 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.78
Capital Spending - 5 Yr. Growth Rate -5.49 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.10 2.12 2.19
Current Ratio (MRQ) 1.34 2.90 2.98
LT Debt to Equity (MRQ) 703.33 9.88 12.19
Total Debt to Equity (MRQ) 728.49 13.86 16.46
Interest Coverage (TTM) 0.70 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.19 54.81 54.46
Gross Margin - 5 Yr. Avg. 72.57 52.15 52.22
EBITD Margin (TTM) 40.41 -- --
EBITD - 5 Yr. Avg 46.61 18.57 10.98
Operating Margin (TTM) -4.24 14.36 4.74
Operating Margin - 5 Yr. Avg. 6.38 14.52 6.41
Pre-Tax Margin (TTM) -24.17 14.82 5.58
Pre-Tax Margin - 5 Yr. Avg. -8.64 14.91 6.83
Net Profit Margin (TTM) -12.35 11.08 1.88
Net Profit Margin - 5 Yr. Avg. -7.44 11.20 3.10
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 429,033 938,104,300 846,855,748
Net Income/Employee (TTM) -52,981 110,371,256 99,619,396
Receivable Turnover (TTM) 3.82 5.63 5.78
Inventory Turnover (TTM) 2.12 2.59 3.35
Asset Turnover (TTM) 0.21 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -2.55 11.40 10.95
Return on Assets - 5 Yr. Avg. -1.87 12.91 12.32
Return on Investment (TTM) -2.83 14.84 14.38
Return on Investment - 5 Yr. Avg. -2.08 16.88 16.11
Return on Equity (TTM) -24.78 16.34 16.08
Return on Equity - 5 Yr. Avg. -11.89 17.98 17.41
  1 Year 3 Year 5 Year
Sales % -7.39 18.80 31.85
EPS (TTM) % -714.91 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Valeant Pharmaceuticals International Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.25 2.58 99 25
13 Week -10.91 -15.24 99 35
26 Week 50.78 39.32 99 29
52 Week -38.94 -48.24 48 12
YTD -0.41 -12.54 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.